About ROXISHOR 25
ROXISHOR 25 by Cipla Pharmaceuticals offers remarkable value for parents seeking potent, pediatric-specific antibiotics. This special, customizable oral tablet contains Roxithromycin 25mg, expertly crafted for children's unique needs. With its round, white, standard pediatric tablet form, ROXISHOR 25 stands out as a virtuoso performer against respiratory tract, skin, soft tissue, and ENT infections. Each blister pack ensures quality, safety, and remarkable efficacy. Prescription is required for use. Experience a reliable solution designed to preserve your child's health with every dose, always under physician guidance.
Versatile Pediatric Antibiotic: Specific and General Uses
ROXISHOR 25 is specifically indicated for respiratory tract, skin, and soft tissue infections, as well as ENT infections in children. Designed for oral administration, this allopathic tablet offers a practical usage type that caters to general and acute pediatric needs. Whether treating common infections or targeted bacterial conditions, it provides a safe and effective value-driven approach. Always use as per pediatrician's guidance to ensure optimal outcomes.
Stock Ready for Main Domestic Market with Trusted Certifications
ROXISHOR 25 is primed for the Indian pharmaceutical market with robust stock ready for immediate shipment. Backed by quality certifications and high market value, it meets the standards demanded by healthcare professionals. Sample availability is provided for institutional buyers, ensuring confidence before bulk orders. With each batch and shipment, Cipla guarantees consistent excellence, making procurement seamless and trustworthy within India's domestic domain.
FAQ's of ROXISHOR 25:
Q: How should ROXISHOR 25 be administered to children?
A: ROXISHOR 25 should be administered orally, strictly following the pediatrician's prescribed dosage. The tablets must be taken with water, and the full course should be completed for best results.
Q: What is the main benefit of using ROXISHOR 25 for pediatric patients?
A: The main benefit is its potent effectiveness against a broad range of bacterial infections, including those affecting the respiratory tract, skin, soft tissues, and ENT, specifically tailored for pediatric use.
Q: Where can ROXISHOR 25 be procured and by whom is it marketed?
A: ROXISHOR 25 is marketed by Cipla Pharmaceuticals and is available through licensed pharmacies or medical suppliers across India. A doctor's prescription is required to purchase this medicine.
Q: What process should be followed if a dose is missed?
A: If a dose is forgotten, it should be taken as soon as possible. However, if it is near the time for the next dose, skip the missed one and continue the regular schedule. Do not double the doses and consult your physician for guidance.
Q: When is ROXISHOR 25 recommended for children?
A: ROXISHOR 25 is recommended when a pediatrician diagnoses bacterial infections such as respiratory, skin, soft tissue, or ENT infections, and prescribes it as a suitable antibiotic therapy.
Q: What storage precautions should be followed for ROXISHOR 25?
A: Store the tablets in a cool, dry place below 30C, away from moisture and sunlight, and out of reach of children. Refer to the packaging for expiry and manufacturing details.